SCHEMBL7124018

SCHEMBL7124018

COc1ccccc1C(=O)[C@@H](Cc1ccccc1)CN(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.48
TP53 P04637 1/20 0.48
GLA P06280 1/20 0.48
ABCB1 P08183 2/20 0.44
NPC1 O15118 2/20 0.44
MAPT P10636 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
RAB9A P51151 1/20 0.44
ATM Q13315 1/20 0.44
GPR52 Q9Y2T5 1/20 0.44
CAPN1 P07384 2/20 0.44
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
MAPK14 Q16539 1/20 0.43
CTSD P07339 1/20 0.43
CYP1A2 P05177 1/20 0.42
LPAR1 Q92633 1/20 0.42
LMNA P02545 1/20 0.42
PPARA Q07869 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7124014 1.00 HPGD (0.48) HPGDTP53GLAABCB1NPC1
Hydrochloric Acid SCHEMBL7164809 0.99 TP53 (0.47) HPGDTP53GLAABCB1NPC1
Hydrochloric Acid SCHEMBL7164811 0.99 TP53 (0.47) HPGDTP53GLAABCB1NPC1
SCHEMBL7164762 0.90 NPC1 (0.50) HPGDTP53GLAABCB1NPC1
SCHEMBL7164755 0.90 NPC1 (0.50) HPGDTP53GLAABCB1NPC1
Hydrochloric Acid SCHEMBL7160426 0.89 NPC1 (0.49) HPGDTP53GLAABCB1NPC1
Hydrochloric Acid SCHEMBL7160432 0.89 NPC1 (0.49) HPGDTP53GLAABCB1NPC1
SCHEMBL7118534 0.86 CAPN1 (0.49) MAPTHTTCAPN1PPARAPPARG
SCHEMBL7118533 0.86 CAPN1 (0.49) MAPTHTTCAPN1PPARAPPARG
SCHEMBL7117569 0.86 PKM (0.48) NPC1MAPTMAPK1HTTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6653508-B2 Use treating various medical conditions, including pain GRUENENTHAL GMBH (DE) 2003-11-25 US claimed
JP-2003505358-A 2003-02-12 JP claimed
US-20020161262-A1 3-Amino-2-benzyl-1-phenylpropane derivatives GRUENTENTHAL GMBH (DE) 2002-10-31 US claimed
EP-1196373-A1 3-AMINO-2-BENZYL-1-PHENYL-PROPANE DERIVATIVES Grünenthal GmbH (DE) 2002-04-17 EP claimed
WO-2001005743-A1 3-AMINO-2-BENZYL-1-PHENYL-PROPANE DERIVATIVES Grünenthal GmbH (DE) 2001-01-25 WO claimed
US-6653508-B2 Use treating various medical conditions, including pain GRUENENTHAL GMBH (DE) 2003-11-25 US disclosed
US-20020161262-A1 3-Amino-2-benzyl-1-phenylpropane derivatives GRUENTENTHAL GMBH (DE) 2002-10-31 US disclosed
EP-1196373-A1 3-AMINO-2-BENZYL-1-PHENYL-PROPANE DERIVATIVES Grünenthal GmbH (DE) 2002-04-17 EP disclosed
WO-2001005743-A1 3-AMINO-2-BENZYL-1-PHENYL-PROPANE DERIVATIVES Grünenthal GmbH (DE) 2001-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020161262-A1 3-Amino-2-benzyl-1-phenylpropane derivatives PYGL, CYP11B2, GOT2 HPGD 548/4885TP53 3123/4885GLA 1369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.